dalteparin has been researched along with Libman-Sacks Disease in 10 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Membranous nephropathy is uncommon in Chinese children and could be a possible early presentation of SLE." | 1.36 | An unusual case of loin pain and nephritis. ( Chiu, MC; Lai, WM; Ma, AL, 2010) |
| "Intravenous magnesium sulfate for seizure prophylaxis and oxytocin for induction of labor were started." | 1.35 | Systemic lupus erythematosus presenting with leukocytoclastic vasculitis and seizure during pregnancy. ( Borahay, MA; Harirah, HM; Kelly, BC, 2009) |
| " Anti-Xa levels may reflect inadequate dosing of low molecular weight heparin, particularly during the first trimester, and should be monitored frequently." | 1.33 | Budd-Chiari syndrome, systemic lupus erythematosus, and secondary antiphospholipid antibody syndrome in pregnancy. ( Aisenbrey, GA; Argubright, KF; Joffe, GM, 2005) |
| "We report a pregnant woman with systemic lupus erythematosus and recurrent venous thromboembolism who suffered from heparin-induced thrombocytopenia type II while treated with dalteparin sodium." | 1.31 | Management of heparin-associated thrombocytopenia in pregnancy with subcutaneous r-hirudin. ( Geberth, M; Harenberg, J; Heene, DL; Hoffmann, U; Huhle, G, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sukhdeo, S | 1 |
| Negroponte, E | 1 |
| Rajasekhar, H | 1 |
| Gaur, S | 1 |
| Horton, DB | 1 |
| Malhotra, A | 1 |
| Moorthy, LN | 1 |
| Bodur, H | 1 |
| Eser, F | 1 |
| Konca, S | 1 |
| Arikan, S | 1 |
| Borahay, MA | 1 |
| Kelly, BC | 1 |
| Harirah, HM | 1 |
| Ma, AL | 1 |
| Lai, WM | 1 |
| Chiu, MC | 1 |
| Dönmez, O | 1 |
| Durmaz, O | 1 |
| Yazbek, MA | 1 |
| Velho, P | 1 |
| Nadruz, W | 1 |
| Mahayri, N | 1 |
| Appenzeller, S | 1 |
| Costallat, LT | 1 |
| Joffe, GM | 1 |
| Aisenbrey, GA | 1 |
| Argubright, KF | 1 |
| Marietta, M | 1 |
| Bertesi, M | 1 |
| Simoni, L | 1 |
| Castelli, I | 1 |
| Cappi, C | 1 |
| Torelli, G | 1 |
| Pauzner, R | 1 |
| Dulitzki, M | 1 |
| Langevitz, P | 1 |
| Livneh, A | 1 |
| Kenett, R | 1 |
| Many, A | 1 |
| Huhle, G | 1 |
| Geberth, M | 1 |
| Hoffmann, U | 1 |
| Heene, DL | 1 |
| Harenberg, J | 1 |
1 trial available for dalteparin and Libman-Sacks Disease
| Article | Year |
|---|---|
Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy.
Topics: Abnormalities, Drug-Induced; Adult; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Autoimmune D | 2001 |
9 other studies available for dalteparin and Libman-Sacks Disease
| Article | Year |
|---|---|
Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus.
Topics: Antiviral Agents; Child, Preschool; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Cy | 2021 |
Infliximab-induced lupus-like syndrome in a patient with ankylosing spondylitis.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Anticoagulants; Antirheumatic Agents; Enoxaparin; | 2009 |
Systemic lupus erythematosus presenting with leukocytoclastic vasculitis and seizure during pregnancy.
Topics: Antibodies, Antinuclear; Anticoagulants; Enoxaparin; Female; Glucocorticoids; Humans; Intracranial T | 2009 |
An unusual case of loin pain and nephritis.
Topics: Adolescent; Cyclosporine; DNA; Enoxaparin; Female; Glomerulonephritis, Membranous; Humans; Immunosup | 2010 |
Calcinosis cutis universalis with pediatric systemic lupus erythematosus.
Topics: Administration, Oral; Antiphospholipid Syndrome; Aspirin; Calcinosis; Child; Cyclosporine; Dermatolo | 2010 |
Extensive skin necrosis induced by low-molecular-weight heparin in a patient with systemic lupus erythematosus and antiphospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aspirin; Drug Eruptions; Drug Therapy, Combination; Enoxaparin; Female; F | 2012 |
Budd-Chiari syndrome, systemic lupus erythematosus, and secondary antiphospholipid antibody syndrome in pregnancy.
Topics: Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Budd-Chiari Syndrome; Cholecystectom | 2005 |
Cerebral vein thrombosis and lupus anticoagulant antibodies.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Autoimmune Diseases; Enoxaparin; Female; Humans; L | 2001 |
Management of heparin-associated thrombocytopenia in pregnancy with subcutaneous r-hirudin.
Topics: Adult; Anticoagulants; Antithrombins; Dalteparin; Female; Heparin; Hirudin Therapy; Humans; Lupus Er | 2000 |